We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The issue could lead to hypercarbia (excessive CO2 in the blood) and/or hypoxemia (low levels of oxygen in the blood) due to the temporary inability to change settings. Read More
One proposed pathway would allow states, wholesalers and pharmacists to submit plans to the FDA for importing prescription drugs approved by Health Canada. Read More
The agency asked manufacturers to voluntarily recall another H2 blocker nizatidine, or Axid, if they find NDMA above the acceptable daily intake level. Read More
The agency can collect backlog fees from holders of ANDAs that were pending on Oct. 1, 2012 and did not receive a tentative approval prior to that date. Read More
Artificial intelligence is “an important asset to reduce human bias when medical professionals triage patients in emergency rooms,” the company said. Read More